Skip to main content
Videos

Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX

July 11, 2022

Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.

 

Contacts

von Mühlenen, Eva
Senior Advisor
Sommer, Josefine
パートナー

Related Resources

Related Blogs

Capabilities

Related Pages

Suggested News & Insights

Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026
Events
Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026
Events
Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026
Events
Global Trial Expansion — Key Considerations for EU/U.S. SponsorsApril 21, 2026
Events
U.S. FDA Issues First Drug Supply Chain Security Act Warning Letter Targeting a Dispenser, Signaling Expanded Enforcement FocusApril 15, 2026
Food, Drug, and Medical Device Update
Navigating the European Health Data Space Regulation: An (Uneasy) Marriage Between EHDS and GDPR (April 2026, Part 2)April 14, 2026
GoodLifeSci